Acucela Inc. Appoints Seasoned Financial Executive, David L. Lowrance, CPA, as Chief Financial Officer
SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, today announced that it has appointed David L. Lowrance, CPA as Chief Financial Officer (CFO). Mr. Lowrance will be responsible for overseeing finance/accounting, corporate communications, legal, information technology (IT), and facilities management; and will report into Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer. Mr. Lowrance brings to Acucela a record of achievement in leading numerous financial transactions, managing commercialization and product launch strategies and helping both smaller and larger companies navigate growth.